We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Vaginal Microbiota Among Postmenopausal Women

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01084616
First Posted: March 10, 2010
Last Update Posted: December 17, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Lawson Health Research Institute
March 9, 2010
March 10, 2010
December 17, 2010
January 2010
July 2010   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01084616 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Vaginal Microbiota Among Postmenopausal Women
The Role of Vaginal Microbiota in Symptoms of Vaginal Dryness in Postmenopausal Women
It is known that vaginal bacteria have an impact upon the health status of the host, in some cases protecting against infection and in other cases causing infection, depending on the bacterial types present. This study will compare the composition of vaginal bacteria to symptoms of vaginal dryness in order to try and identify if certain bacteria might cause some of the problems associated with vaginal dryness among post-menopausal women.
Not Provided
Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample
Postmenopausal women
Vulvovaginal Atrophy
Not Provided
  • Vaginal Dryness
  • Non-vaginal dryness
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
16
July 2010
July 2010   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Between 30 and 80 years old.
  • Postmenopausal = 12 months of spontaneous amenorrhea or 6 months of spontaneous amenorrhea with serum FSH levels > 40 mIU/ml or 6 weeks postsurgical bilateral oophorectomy with or without hysterectomy.
  • Prepared not to take hormone replacement therapy during 8 weeks follow-up and not taking estrogen alone or estrogen/progestin containing drug products at the time of screening.
Sexes Eligible for Study: Female
30 Years to 80 Years   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Canada
 
 
NCT01084616
R-09-804
16182E ( Other Identifier: Research Ethics Board )
No
Not Provided
Not Provided
Dr. Gregor Reid, Lawson Health Research Institute
Lawson Health Research Institute
Not Provided
Principal Investigator: Gregor Reid, PhD Lawson Health Research Institute
Lawson Health Research Institute
December 2010